C
Coherus BioSciences D
D
CHRS
1.78000
USD
0.08
(4.40%)
مغلق
حجم التداول
26,936
الربح لكل سهم
-1
العائد الربحي
-
P/E
3
حجم السوق
206,884,550
العنوان: Coherus Oncology Inc
القطاع: Healthcare
الصناعة: Biotechnology
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.